Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
wE36NLPfhvzCD9gj
